Cogstate jumps 51pc on Alzheimer’s drug news
MELBOURNE: Shares in Cogstate, a neuroscience technology company backed by the Myer family, rocketed 60… read more
New Alzheimer’s drug unlikely to be approved in Australia
CANBERRA: A controversial new drug that has offered hope to Alzheimer’s sufferers by slowing cognitive… read more
Ryman Healthcare set to sell school site for $21m
MELBOURNE: Ryman Healthcare has sold its1.2ha parcel of land at Coburg to a private residential… read more
Ryman to rework large retirement village design after backlash
CHRISTCHURCH: A plan by Ryman to build its biggest retirement complex in Christchurch has upset… read more
